As of Nov 4, 2026, ORTEX estimated 2.2% of free float sold short, 2.5 days to cover, cost to borrow 0.19%. Sign up for live short interest data.
As of Nov 4, 2026, ORTEX estimated 2.2% of free float sold short, 2.5 days to cover, cost to borrow 0.19%. Sign up for live short interest data.
This page tracks how heavily Regeneron Pharmaceuticals (Nasdaq:REGN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Regeneron Pharmaceuticals (Nasdaq: REGN) has a market capitalization of $96.11B. Last close $923.34 (as of 2026-11-20); 52-week range $591.52 to $991.73. ORTEX data as of 2026-11-04: short interest was 2.23% of free float, 2.5 days to cover and the average cost to borrow was 0.19%. Sign up for live short interest data.